Literature DB >> 4719636

[Phenotypes of erythrocytic glucose-6-phosphate dehydrogenase in black people. Examination of 301 black people living in France and description of 9 different variants. High incidence of deficiency of an enzyme of "B" mobility].

A Kahn, P Boivin, J Lagneau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4719636     DOI: 10.1007/BF00290606

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


× No keyword cloud information.
  21 in total

1.  HUMAN RED-CELL PHOSPHOGLUCONATE DEHYDROGENASES.

Authors:  R A FILDES; C W PARR
Journal:  Nature       Date:  1963-11-30       Impact factor: 49.962

2.  Glucose 6-phosphate dehydrogenase of human erythrocytes. I. Purification and characterization of normal (B+) enzyme.

Authors:  A Yoshida
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

Review 3.  Drug-induced hemolytic anemia.

Authors:  E Beutler
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

4.  Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.

Authors:  S Piomelli; C A Reindorf; M T Arzanian; L M Corash
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

5.  Glucose-6-phosphate dehydrogenase Madrona: a slow electrophoretic glucose-6-phosphate dehydrogenase variant with kinetic characteristics similar to those of normal type.

Authors:  E B Hook; G Stamatoyannopoulos; A Yoshida; A G Motulsky
Journal:  J Lab Clin Med       Date:  1968-09

6.  Genetic studies on southeastern Bantu of Mozambique. I. Variants of glucose-6-phosphate dehydrogenase.

Authors:  L Reys; C Manso; G Stamatoyannopoulos
Journal:  Am J Hum Genet       Date:  1970-03       Impact factor: 11.025

7.  Glucose-6-phosphate dehydrogenase deficiency in Canadian Negroes.

Authors:  G R Langley; F R Todd; A J Bishop
Journal:  Can Med Assoc J       Date:  1969-06-07       Impact factor: 8.262

8.  Glucose-6-phosphate dehydrogenase deficiency, hemoglobin and haptoglobin types in Mexicans and American Negroes.

Authors:  S N Naik; D E Anderson
Journal:  Tex Rep Biol Med       Date:  1971

9.  Enzymic properties of different types of human erythrocyte glucose-6-phosphate dehydrogenase, with characterization of two new genetic variants.

Authors:  L Luzzatto; A Afolayan
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

10.  Evidence for four types of erythrocyte glucose-6-phosphate dehydrogenase from G-6-PD-deficient human subjects.

Authors:  P V Pinto; W A Newton; K E Richardson
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

View more
  6 in total

1.  A new variant of human erythrocyte G6PD occurring at a high frequency amongst the population of two villages in The Gambia, West Africa.

Authors:  S G Welch; I A McGregor; K Williams
Journal:  Hum Genet       Date:  1978-02-16       Impact factor: 4.132

2.  Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency.

Authors:  A Kahn; D Cottreau; P Boivin
Journal:  Humangenetik       Date:  1974

3.  Defective molecular variants of glucose-6-phosphate dehydrogenase and methaemoglobin reductase.

Authors:  J C Kaplan
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  A variant glucose-6-phosphate dehydrogenase Gd(-) Chiapas associated with moderate enzyme deficiency and occasional hemolytic anemia.

Authors:  R Lisker; R P Briceno; L Agrilar; A Yoshida
Journal:  Hum Genet       Date:  1978-07-12       Impact factor: 4.132

5.  'Gd(-) Hôtel Dieu': a new G-6PD variant with chronic hemolysis in a Negro patient from Senegal.

Authors:  A Kahn; C Dao; D Cottreau; G Bilski-Pasquier
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

Review 6.  Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.

Authors:  Wuelton M Monteiro; Gabriel P Franca; Gisely C Melo; Amanda L M Queiroz; Marcelo Brito; Henry M Peixoto; Maria Regina F Oliveira; Gustavo A S Romero; Quique Bassat; Marcus V G Lacerda
Journal:  Malar J       Date:  2014-02-25       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.